Disease & disorder

brain neoplasm

MONDO:0021211

A neoplasm (disease) that involves the brain.

Clinical trials54
Recruiting14
Drug concepts studied18
Synonyms10

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

brain neoplasm

Wikidata Q9303627 ↗
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossNCT06810544 · 2025-03-24
RECRUITING
Brodalumab in the Treatment of Immune-Related Adverse EventsNCT06673329 · 2025-03-11
RECRUITING
Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal AssessmentNCT06352710 · 2023-06-12
RECRUITING
Remote Neuropsychological Assessment of Patients With Neurological Disorders and InjuriesNCT05819008 · 2023-03-10
RECRUITING
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omicsNCT06001073 · 2022-12-05
RECRUITING
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerNCT05386108 · 2022-08-31
RECRUITING
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor PatientsNCT05549024 · 2022-08-16
RECRUITING
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain MetsNCT05317858 · 2022-08-12
RECRUITING
Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid TumorsNCT06128148 · 2022-05-04
RECRUITING
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain MetastasesNCT04899908 · 2021-09-15
RECRUITING
18F-DOPA II - PET Imaging OptimizationNCT04706910 · 2021-01-20
RECRUITING
Engineered TILs/CAR-TILs to Treat Advanced Solid TumorsNCT04842812 · 2021-01-01
RECRUITING
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNCT04075305 · 2019-02-01
RECRUITING
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsNCT03175224 · 2017-09-27
RECRUITING
Non-invasive Intracranial Pressure Monitoring in Brain Tumor PatientsNCT07286396 · 2026-01-01
NOT_YET_RECRUITING
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast AgentNCT06322342 · 2024-08-15
COMPLETED
CALM: Managing Distress in Malignant Brain CancerNCT06180460 · 2023-11-10
COMPLETED
The Effect of 360° Virtual Reality Movies on Fear and AnxietyNCT06199050 · 2023-06-16
COMPLETED
The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of ActionNCT05926336 · 2023-05-23
UNKNOWN
Post Market Clinical Follow-up of CODMAN CERTAS Programmable ValveNCT05397106 · 2023-01-24
ACTIVE_NOT_RECRUITING
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsNCT05538130 · 2022-11-30
ACTIVE_NOT_RECRUITING
Dynamic Decompressive CraniotomyNCT05051488 · 2022-04-30
UNKNOWN
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.NCT04712721 · 2021-10-14
TERMINATED
Neuropsychology of Financial CapacityNCT05791006 · 2021-08-04
UNKNOWN
Improving Social Cognition and Social Behaviour in Various Brain DisordersNCT06330298 · 2021-05-31
UNKNOWN
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsNCT04644315 · 2021-05-24
TERMINATED
The Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05
COMPLETED
A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain InvolvementNCT04543188 · 2021-01-08
TERMINATED
Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During RadiotherapyNCT04517019 · 2020-08-01
UNKNOWN
Closed vs. Open Face Masks for Cranial RadiotherapyNCT04079595 · 2019-12-09
COMPLETED
Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?NCT06251830 · 2018-09-01
COMPLETED
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy SurgeryNCT04344626 · 2018-07-16
WITHDRAWN
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceNCT02900248 · 2017-10-02
TERMINATED
Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II TrialNCT02655536 · 2017-08-01
UNKNOWN
An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring DeviceNCT02773888 · 2015-12-01
SUSPENDED
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133NCT02541370 · 2015-06-01
COMPLETED
PatientSpot Formerly Known as ArthritisPowerNCT03840928 · 2015-04-01
UNKNOWN
Assessing the Patient Experience in Cancer CareNCT01621295 · 2012-05-01
COMPLETED
Ultrasound Guided Central Vein Catheterization and ComplicationsNCT01510743 · 2012-01-30
COMPLETED
Social Cognition in Children Treated for a Brain TumourNCT01599052 · 2011-03-01
COMPLETED

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.